## **Core Concept**
The question tests understanding of the neurochemical hypotheses of schizophrenia, particularly focusing on the neurotransmitters involved in the pathophysiology of both positive and negative symptoms of the disorder. Schizophrenia is a complex mental disorder characterized by a range of symptoms, including positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., apathy, social withdrawal). The dopamine hypothesis is a well-established theory, but other neurotransmitters are also implicated.

## **Why the Correct Answer is Right**
The correct answer, **Glutamate**, is implicated in both positive and negative symptoms of schizophrenia through its interaction with various glutamatergic receptors, particularly the N-methyl-D-aspartate (NMDA) receptor. Glutamate is the primary excitatory neurotransmitter in the central nervous system and plays a critical role in cognitive functions such as learning and memory. Dysfunction in glutamatergic neurotransmission has been linked to the pathophysiology of schizophrenia, potentially affecting both positive symptoms, through its interaction with dopamine release, and negative symptoms, by impacting cognitive and emotional processing.

## **Why Each Wrong Option is Incorrect**
- **Option A: Dopamine** - While dopamine is strongly implicated in the positive symptoms of schizophrenia, its role in negative symptoms is less direct. Dopamine dysregulation is a core aspect of the dopamine hypothesis of schizophrenia, but it doesn't fully account for the breadth of symptoms, especially negative symptoms.
- **Option B: Serotonin** - Serotonin is involved in mood regulation and has been implicated in various psychiatric disorders, including depression and anxiety. While it may play a role in schizophrenia, particularly in mood symptoms, it is not primarily associated with both positive and negative symptoms.
- **Option D: GABA** - GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain. Although GABAergic dysfunction has been implicated in schizophrenia, its role is more related to the modulation of neural circuits rather than being directly implicated in both positive and negative symptoms.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **glutamate hypothesis** of schizophrenia offers a potential explanation for the cognitive and negative symptoms of the disorder, which are often less responsive to traditional antipsychotic medications that primarily target dopamine receptors. This highlights the need for novel therapeutic strategies targeting glutamatergic neurotransmission.

## **Correct Answer:** . Glutamate